The aim of the study is to evaluate the effectiveness and the safety of the cyclocoagulation using HIFU in glaucoma patients
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Ultrasound glaucoma treatment with EYEOP1 device
University Hospital
Dijon, France
Michallon University Hospital
Grenoble, France
Huriez University Hospital
Lille, France
Croix Rousse University Hospital
Lyon, France
HIA - Val de Grace Hospital
Success rate : Proportion of eyes that achieve an IOP of > 5 mmHg and <21 mmHg or an IOP reduction > 20%
Success rate = complete success rate (achieved without ocular hypotensive medication) + qualified success (achieved with ocular hypotensive medication)
Time frame: up to 12 months
Average change in IOP (mm Hg)
Time frame: 3, 6 and 12 months
Percentage change in IOP from baseline
Time frame: 3, 6 and 12 months
Average change in glaucoma hypotensive medications
Time frame: 3, 6 and 12 months
Incidence of device and procedure-related complications during follow-up
Time frame: 3, 6 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Paris, France